KEMPENI, JOACHIM,WEISS, ROBERTA,FISCHKOFF, STEVEN A
申请号：
NZ58606302
公开号：
NZ586063A
申请日:
2002.06.05
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Provided is the use of an isolated human anti-TNFalpha antibody, or an antigen-binding portion thereof, in the manufacture of a medicament for treating a human subject having rheumatoid arthritis, wherein the medicament is adapted for biweekly administration as a 40 mg 5 dose, and wherein the human anti-TNFalpha antibody, or antigen-binding portion thereof, has specified CDR sequences or sequences with one to five conservative amino acid substitutions.
